{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T23:20:41Z","timestamp":1768000841764,"version":"3.49.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T00:00:00Z","timestamp":1744934400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T00:00:00Z","timestamp":1744934400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2024JJ9223"],"award-info":[{"award-number":["2024JJ9223"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2024JJ6566"],"award-info":[{"award-number":["2024JJ6566"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019081","name":"Science and Technology Program of Hunan Province","doi-asserted-by":"publisher","award":["D202303049242"],"award-info":[{"award-number":["D202303049242"]}],"id":[{"id":"10.13039\/501100019081","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Glanzmann thrombasthenia (GT) is a rare inherited bleeding disorder caused by dysfunction of the integrin \u03b1IIb\u03b23 in platelets. The subunit \u03b23, encoded by <jats:italic>ITGB3<\/jats:italic> also plays a significant role in bone metabolism. Whether GT patients with \u03b23 deficiency also suffer from bone pathology remains unclear.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Method<\/jats:title>\n            <jats:p>The 21-year-old female patient presenting with bleeding diathesis and multiple congenital bone defects in her right hand, and her seven family members were included in the study. Whole exome sequencing as well as Sanger sequencing were conducted to identify GT-associated mutations within the family. The platelet function of the family was detected by the platelet aggregation test and thromboelastography (TEG). The expression levels of CD41 (\u03b1IIb) and CD61 (\u03b23) on the platelet surface and total in platelet were detected by flow cytometry and Western blot. Bioinformatics analysis was used to evaluate the pathogenicity of mutation sites and their effects on protein structure and function. X-ray imaging, bone densitometry and bone metabolism index were performed to evaluate bone development and metabolism.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Result<\/jats:title>\n            <jats:p>A novel homozygous frameshift mutation c.2143_2158delinsCT (p.Lys715Leufs*36) of <jats:italic>ITGB3<\/jats:italic> was found in the proband. Platelet aggregation by ADP, collagen, epinephrine, and arachidonic acid was absent, TEG showed hypocoagulability and decreased platelet function, and the expression levels of \u03b1IIb and \u03b23 on the platelet surface and total in platelet were significantly reduced (&lt;\u20095%) in the proband. The parents, second elder sister and grandmother of proband were heterozygous carriers without bleeding symptoms and had normal platelet aggregation function and \u03b1IIb\/\u03b23 protein expression. Structural modeling strongly suggested that the mutation creates a truncation in cytoplasmic domains of \u03b23, resulting in the mutant \u03b23\/\u03b1IIb\u03b23 inactivated and low expression. The proband was born with partial absence of phalanges in digits 2\u20134 and the deformity of fingers 1 and 5 in her right hand, bone densitometry indicated significant osteopenia and increased risk of fracture in her right radius, and no other gene mutations related to bone pathology were identified.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>A novel mutation of <jats:italic>ITGB3<\/jats:italic> which results in GT was identified. This is the third reported case of GT combined with bone defect. Our work expands <jats:italic>ITGB3<\/jats:italic> mutation spectrum and provide further insights into the potential association between GT and bone development and metabolism.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13023-025-03700-9","type":"journal-article","created":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T05:16:12Z","timestamp":1744953372000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Novel homozygous frameshift mutation of ITGB3 in the Glanzmann thrombasthenia patient with abnormal bone metabolism and congenital bone defects"],"prefix":"10.1186","volume":"20","author":[{"given":"Yujiao","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yewei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,18]]},"reference":[{"key":"3700_CR1","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1002\/humu.23626","volume":"39","author":"AN Abou Tayoun","year":"2018","unstructured":"Abou Tayoun AN, Pesaran T, DiStefano MT, Oza A, Rehm HL, Biesecker LG, Harrison SM. ClinGen sequence variant interpretation working G. Recommendations for interpreting the loss of function PVS1 ACMG\/AMP variant criterion. Hum Mutat. 2018;39:1517\u201324. Epub 2018\/09\/08.","journal-title":"Hum Mutat"},{"key":"3700_CR2","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med. 2015;17:405\u201324. Epub 2015\/03\/06.","journal-title":"Genet Med"},{"key":"3700_CR3","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1038\/s41594-023-01139-9","volume":"30","author":"J Aretz","year":"2023","unstructured":"Aretz J, Aziz M, Strohmeyer N, Sattler M, Fassler R. Talin and kindlin use integrin tail allostery and direct binding to activate integrins. Nat Struct Mol Biol. 2023;30:1913\u201324. Epub 2023\/12\/13.","journal-title":"Nat Struct Mol Biol"},{"key":"3700_CR4","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.apsb.2022.09.020","volume":"13","author":"S Chen","year":"2023","unstructured":"Chen S, He T, Zhong Y, Chen M, Yao Q, Chen D, Shao Z, Xiao G. Roles of focal adhesion proteins in skeleton and diseases. Acta Pharm Sin B. 2023;13:998\u20131013. Epub 2023\/03\/28.","journal-title":"Acta Pharm Sin B"},{"key":"3700_CR5","doi-asserted-by":"publisher","first-page":"e6070","DOI":"10.1002\/ccr3.6070","volume":"10","author":"K Aso","year":"2022","unstructured":"Aso K, Soutome T, Satoh M, Aoki T, Ogura H, Yamamoto T, Kanno H, Takahashi H. Association of autosomal-recessive-type distal renal tubular acidosis and Glanzmann thrombasthenia as a consequence of runs of homozygosity. Clin Case Rep. 2022;10:e6070. Epub 2022\/07\/23.","journal-title":"Clin Case Rep"},{"key":"3700_CR6","doi-asserted-by":"publisher","first-page":"888","DOI":"10.3324\/haematol.2018.214239","volume":"105","author":"JP Botero","year":"2020","unstructured":"Botero JP, Lee K, Branchford BR, Bray PF, Freson K, Lambert MP, Luo M, Mohan S, Ross JE, Bergmeier W, et al. Glanzmann thrombasthenia: genetic basis and clinical correlates. Haematologica. 2020;105:888\u201394. Epub 2020\/03\/07.","journal-title":"Haematologica"},{"key":"3700_CR7","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.blre.2017.03.005","volume":"31","author":"AT Nurden","year":"2017","unstructured":"Nurden AT. Should studies on Glanzmann thrombasthenia not be telling Us more about cardiovascular disease and other major illnesses? Blood Rev. 2017;31:287\u201399. Epub 2017\/04\/12.","journal-title":"Blood Rev"},{"key":"3700_CR8","doi-asserted-by":"publisher","first-page":"547","DOI":"10.3109\/09537104.2011.573600","volume":"22","author":"AT Nurden","year":"2011","unstructured":"Nurden AT, Fiore M, Nurden P, Heilig R, Pillois X. Are bone defects in rare patients with Glanzmann\u2019s thrombasthenia associated with ITGB3 or ITGA2B mutations? Platelets. 2011;22:547\u201351. Epub 2011\/05\/12.","journal-title":"Platelets"},{"key":"3700_CR9","doi-asserted-by":"publisher","first-page":"152073","DOI":"10.1016\/j.acthis.2023.152073","volume":"125","author":"D Yu","year":"2023","unstructured":"Yu D, Li Z, Cao J, Wei G, Shen F. LSD1 knockdown confers protection against osteoclast formation by reducing histone 3 lysine 9 monomethylation and dimethylation in ITGB3 promoter. Acta Histochem. 2023;125:152073. Epub 2023\/07\/09.","journal-title":"Acta Histochem"},{"key":"3700_CR10","doi-asserted-by":"crossref","unstructured":"Rashid S, Wilson SG, Zhu K, Walsh JP, Xu J, Mullin BH. Identification of differentially expressed genes and molecular pathways involved in osteoclastogenesis using RNA-seq. Genes (Basel) 2023;14. Epub 2023\/04\/28.","DOI":"10.3390\/genes14040916"},{"key":"3700_CR11","doi-asserted-by":"publisher","first-page":"151926","DOI":"10.1016\/j.acthis.2022.151926","volume":"124","author":"D Yu","year":"2022","unstructured":"Yu D, Li Z, Cao J, Shen F, Wei G. microRNA-25-3p suppresses osteogenic differentiation of BMSCs in patients with osteoporosis by targeting ITGB3. Acta Histochem. 2022;124:151926. Epub 2022\/07\/02.","journal-title":"Acta Histochem"},{"key":"3700_CR12","doi-asserted-by":"publisher","first-page":"e18183","DOI":"10.1111\/jcmm.18183","volume":"28","author":"L Yang","year":"2024","unstructured":"Yang L, Chen H, Yang C, Hu Z, Jiang Z, Meng S, Liu R, Huang L, Yang K. Research progress on the regulatory mechanism of integrin-mediated mechanical stress in cells involved in bone metabolism. J Cell Mol Med. 2024;28:e18183. Epub 2024\/03\/20.","journal-title":"J Cell Mol Med"},{"key":"3700_CR13","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1172\/JCI5487","volume":"103","author":"KM Hodivala-Dilke","year":"1999","unstructured":"Hodivala-Dilke KM, McHugh KP, Tsakiris DA, Rayburn H, Crowley D, Ullman-Cullere M, Ross FP, Coller BS, Teitelbaum S, Hynes RO. Beta3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival. J Clin Invest. 1999;103:229\u201338. Epub 1999\/01\/23.","journal-title":"J Clin Invest"},{"key":"3700_CR14","doi-asserted-by":"publisher","first-page":"6738","DOI":"10.1158\/0008-5472.CAN-09-0949","volume":"69","author":"M Tucci","year":"2009","unstructured":"Tucci M, De Palma R, Lombardi L, Rodolico G, Berrino L, Dammacco F, Silvestris F. beta(3) integrin subunit mediates the bone-resorbing function exerted by cultured myeloma plasma cells. Cancer Res. 2009;69:6738\u201346. Epub 2009\/08\/06.","journal-title":"Cancer Res"},{"key":"3700_CR15","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1007\/s00277-002-0571-3","volume":"82","author":"N Yarali","year":"2003","unstructured":"Yarali N, Fisgin T, Duru F, Kara A. Osteopetrosis and Glanzmann\u2019s thrombasthenia in a child. Ann Hematol. 2003;82:254\u20136. Epub 2003\/04\/23.","journal-title":"Ann Hematol"},{"key":"3700_CR16","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1096\/fj.09-138420","volume":"24","author":"EA Morgan","year":"2010","unstructured":"Morgan EA, Schneider JG, Baroni TE, Uluckan O, Heller E, Hurchla MA, Deng H, Floyd D, Berdy A, Prior JL, et al. Dissection of platelet and myeloid cell defects by conditional targeting of the beta3-integrin subunit. FASEB J. 2010;24:1117\u201327. Epub 2009\/11\/26.","journal-title":"FASEB J"},{"key":"3700_CR17","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1182\/blood.V91.5.1562","volume":"91","author":"CM Grimaldi","year":"1998","unstructured":"Grimaldi CM, Chen F, Wu C, Weiss HJ, Coller BS, French DL. Glycoprotein IIb Leu214Pro mutation produces Glanzmann thrombasthenia with both quantitative and qualitative abnormalities in GPIIb\/IIIa. Blood. 1998;91:1562\u201371. Epub 1998\/03\/21.","journal-title":"Blood"},{"key":"3700_CR18","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jot.2023.05.001","volume":"40","author":"L Qin","year":"2023","unstructured":"Qin L, Chen Z, Yang D, He T, Xu Z, Zhang P, Chen D, Yi W, Xiao G. Osteocyte beta3 integrin promotes bone mass accrual and force-induced bone formation in mice. J Orthop Translat. 2023;40:58\u201371. Epub 2023\/07\/17.","journal-title":"J Orthop Translat"},{"key":"3700_CR19","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1093\/abbs\/gmaa174","volume":"53","author":"Z Zou","year":"2021","unstructured":"Zou Z, Liu R, Wang Y, Xing Y, Shi Z, Wang K, Dong D. IL1RN promotes osteoblastic differentiation via interacting with ITGB3 in osteoporosis. Acta Biochim Biophys Sin (Shanghai). 2021;53:294\u2013303. Epub 2021\/01\/26.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"3700_CR20","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s10020-024-00822-x","volume":"30","author":"X Geng","year":"2024","unstructured":"Geng X, Tang Y, Gu C, Zeng J, Zhao Y, Zhou Q, Jia L, Zhou S, Chen X. Integrin alphaVbeta3 antagonist-c(RGDyk) peptide attenuates the progression of ossification of the posterior longitudinal ligament by inhibiting osteogenesis and angiogenesis. Mol Med. 2024;30:57. Epub 2024\/05\/03.","journal-title":"Mol Med"},{"key":"3700_CR21","doi-asserted-by":"publisher","first-page":"7261","DOI":"10.1074\/jbc.RA120.013024","volume":"295","author":"DY Yuh","year":"2020","unstructured":"Yuh DY, Maekawa T, Li X, Kajikawa T, Bdeir K, Chavakis T, Hajishengallis G. The secreted protein DEL-1 activates a beta3 integrin-FAK-ERK1\/2-RUNX2 pathway and promotes osteogenic differentiation and bone regeneration. J Biol Chem. 2020;295:7261\u201373. Epub 2020\/04\/14.","journal-title":"J Biol Chem"},{"key":"3700_CR22","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1080\/03008207.2024.2396002","volume":"65","author":"M Tollabi","year":"2024","unstructured":"Tollabi M, Poursalehi Z, Mehrafshar P, Bakhtiari R, Hosseinpour Sarmadi V, Tayebi L, Haramshahi SMA. Insight into the role of integrins and integrins-targeting biomaterials in bone regeneration. Connect Tissue Res. 2024;65:343\u201363. Epub 2024\/09\/22 20:51.","journal-title":"Connect Tissue Res"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03700-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03700-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03700-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T05:16:15Z","timestamp":1744953375000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03700-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,18]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3700"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03700-9","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,18]]},"assertion":[{"value":"12 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Committee of Medical Ethics of The Second XiangYa Hospital of Central South University. Written informed consent was obtained from all the participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agree to the publication of this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"We declare that we have no conflict of interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"189"}}